ARCUTIS THERAPEUTICS

Membership Level: Standard Industry

Arcutis Biotherapeutics, Inc. is a medical dermatology company that champions meaningful innovation to solve the most persistent challenges of patients with immune-mediated dermatological diseases and conditions. Founded in 2016, Arcutis went public in January 2020. In July 2022, Arcutis received FDA approval for their first product, SORYVE, a topical cream for the treatment of plaque psoriasis. Arcutis now has offices in Park City, Utah.

We welcome, CEO, Frank Watanabe, and the Arcutis team to the BioHive!!!

More